The DayOne Accelerator has helped launch more than 75 innovative healthtech ventures since we started operating in 2018. You can find details of all our active alumni companies below.
Latest update: 01/09/2026
Portfolio
In the spotlight
Oncoustics
Oncoustics applies AI to raw sound signals on low-cost ultrasound devices turning these into powerful virtual biopsy tools that will democratize diagnostics.
FindMeCure / Trialhub
TrialHub: Insights that turn trials into treatments.
Theremia
Theremia is an AI-driven platform that optimizes drug development by ensuring pharmaceutical companies create the right drug for the right population subgroups.
Risklick
Revolutionizing clinical trial protocol with first-in-class AI software.
Senseera Health
Senseera’s goal is to transform precision medicine for every patient and pioneer liver diagnostics through groundbreaking chromatin epigenomics.
Portfolio
Company
Therapeutic areas
Country
Funding Stage
Development stage
Virtuosis AI
Therapeutic area: Brain Health, Cardiovascular diseases, Chronic diseases, Neurology, Preventive Health
Country: Switzerland
Funding Stage: Pre seed
Development stage: Commercial launch
AI models analyzing vocal biomarkers for NCS, cardiometabolic and respiratory disorders.
Visit website
Brain Health, Cardiovascular diseases, Chronic diseases, Neurology, Preventive Health
Switzerland
Pre seed
Commercial launch
Wemedoo
Therapeutic area: Oncology, Ophtalmology, z-Other
Country: Switzerland
Funding Stage: Serie A
Development stage: Commercial launch
Unified clinical trial software and services turning fragmented clinical data into real-time insights.
Visit website
Oncology, Ophtalmology, z-Other
Switzerland
Serie A
Commercial launch
ZebraMed
Therapeutic area: Agnostic, Brain Health, Immunology
Country: France
Funding Stage: Bootstrapped or grants only
Development stage: Preclinical research and prototyping
AI-powered zebrafish platform generating human-relevant preclinical insights for target discovery and candidate optimization.
Visit website
Agnostic, Brain Health, Immunology
France
Bootstrapped or grants only
Preclinical research and prototyping
Zoundream
Therapeutic area: Pediatrics
Country: Switzerland
Funding Stage: Serie A
Development stage: Commercial launch
AI-based cry analysis that translates baby sounds and flags early infant health risks.
Visit website
Pediatrics
Switzerland
Serie A
Commercial launch
ZuriEV
Therapeutic area: Oncology
Country: Switzerland
Funding Stage: Pre seed
Development stage: Design & development
Blood-based liquid biopsy test enabling earlier, non-invasive brain cancer diagnosis.
Visit website
Oncology
Switzerland
Pre seed
Design & development
